Eve Burstein
Stock Analyst at Bernstein
(1.71)
# 2,918
Out of 4,810 analysts
22
Total ratings
38.46%
Success rate
-0.29%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $135 → $145 | $103.12 | +40.61% | 3 | Jan 10, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $151.74 | +31.80% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $95.54 | +51.77% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $323.44 | +11.30% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $43.67 | +106.09% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $44.85 | -21.96% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $441.00 | +40.59% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.27 | +96.85% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $15.40 | +42.86% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $74.59 | +48.81% | 1 | Sep 28, 2023 |
Agilent Technologies
Jan 10, 2025
Maintains: Market Perform
Price Target: $135 → $145
Current: $103.12
Upside: +40.61%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $151.74
Upside: +31.80%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $95.54
Upside: +51.77%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $323.44
Upside: +11.30%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $43.67
Upside: +106.09%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $44.85
Upside: -21.96%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $441.00
Upside: +40.59%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.27
Upside: +96.85%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $15.40
Upside: +42.86%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $74.59
Upside: +48.81%